Presentation
Most commonly, patients will present with a 'self' detected mass in the involved testis. The mass is usually painless but occasionally pain and dragging may be described.
Other modes of presentation include:
- Incidental finding on imaging or bloods performed for unrelated problems
- Symptoms of metastatic disease (very rare for seminoma)
Initial Consult
History of Presenting Complaint
- When the lump was first noticed
- Any symptoms associated with the lump
Past Medical History
- Previous inguinal surgery
- Undescended testis as a child
- Other medical problems
Medications/Allergies
- Standard questions only
Family History
- Any history of germ cell tumours in the family (about 1 - 2% hereditary)
Social History
- Current fertility status (subfertility is commonly associated with malignancy)
- Plans for further children (radiotherapy may render patient sterile)
- Ability to attend radiotherapy
- Home supports
- Work
Examinations
- Examine contralateral testis (50 fold increased risk for development of disease in other testis)
- Examine location of scar (dissemination of disease to scrotum can cause lymphatic spread to inguinal and iliac nodes)
- Examine lymph nodes of inguinal region, supraclavicular fossa and axilla (possible sites of spread for advanced disease)
- Examine chest (common site of haematogenous spread)
- Examine abdomen (for bulky abdominal nodes, liver metastases)
Investigations
- Must be staged with CT Chest/Abdomen/Pelvis to identify lymphatic/haematogenous metastases
- AFP / β-hCG / LDH commonly performed but usually negative in seminoma (β-hCG may be elevated in a population with syncytiotrophoblasts mixed with seminoma cells)
- These are useful markers if disease has transformed to a more aggressive form (teratoma, choriocarcinoma)
Staging
TNM Staging
TNM staging is unusual for testicular malignancy, as metastatic disease is Stage III, there is no Stage IV, and tumour markers are included in staging.
T Stage
T0 - No evidence of primary tumour
Tis - Intratubular germ cell neoplasia (carcinoma in situ)
T1 - Limited to testis/epididymis, no lymphovascular invasion, may invade tunica albuginea but not tunica vaginalis
T2 - As for T1 but with lymphovascular invasion and/or the tunia vaginalis
T3 - Invasion of spermatic cord
T4 - Invasion of scrotum
N Stage
N0 - No evidence of lymph node metastases
N1 - Involvement of para-aortic lymph nodes, no mass < 2 cm
N2 - Involvement of para-aortic lymph nodes, individual masses 2 - 5 cm
N3 - Involvement of para-aortic lymph nodes, at least one mass > 5 cm
M Stage
M0 - No evidence of distant metastases
M1a - Other lymphadenopathy or pulmonary metastases
M1b - Metastases to other areas
S Stage
Stage | β-hCG | AFP | LDH |
---|---|---|---|
S0 | Not elevated | Not elevated | Not elevated |
S1 | < 5,000 | < 1,000 | < 1.5 × normal |
S2 | 5,000 - 10,000 | 1,000 - 10,000 | 1.5 - 10 × normal |
S3 | > 10,000 | > 10,000 | > 10 × normal |
Final Stage
Stage | T stage | N stage | M stage | S stage |
---|---|---|---|---|
0 | Tis | N0 | M0 | S0 |
IA | T1 | N0 | M0 | S0 |
IB | T2-4 | N0 | M0 | S0 |
IS | Any | N0 | M0 | S1-3 |
IIA | Any | N1 | M0 | S0-1 |
IIB | Any | N2 | M0 | S0-1 |
IIC | Any | N3 | M0 | S0-1 |
IIIA | Any | Any | M1a | S0-1 |
IIIB | Any | Any | M1a | S2 |
IIIC | Any | Any | M1a | S3 |
IIIC | Any | Any | M1b | Any |